“The New Algorithm Analysizes Gene Chips To Detect Certain Cancer Genes”
(June 1) New Materials International reports, “Researchers at New York University's Courant Institute of Mathematical Sciences have developed a new algorithm that makes it much easier to detect certain cancer genes, and as a test, have applied it to map a set of tumor-suppressor genes involved in lung cancer.”
“Jefferson Scientists Identify Gene Mutation Potentially Involved in Breast Cancer Initiation”
(May 31) Thomas Jefferson University Hospital reports, “Researchers at Jefferson Medical College and the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia and at the Albert Einstein College of Medicine in New York have found evidence suggesting that a mutation in a gene that normally helps block the formation of breast tumors could play a role in the initiation of a major form of breast cancer.”
“Overcoming A Genetic Defect”
(May 31) Medical News Today reports, “The European Union has approved a grant of about € 2.4 million to a team of European scientists, led by the Kiel biochemist Professor Paul Saftig, to carry out research on the rare hereditary disease alpha-mannosidosis.”
“Blood Compatibility - It's All In The Genes!”
(May 30) Medical News Today reports, “In most developed countries safe blood transfusion is taken for granted. But blood grouping is a complex business, and not all blood groups are compatible.”
“Genetic disorder could cause strokes”
(May 30) WebIndia123.com reports, “A rare genetic disorder may be responsible for causing strokes in young people, though the condition''s progress can be slowed using enzyme replacement treatment, says a study.”
“Research Suggests Cause Of Neurodegeneration In Huntington's Disease”
(May 30) Science Daily reports, “The severe neurodegeneration associated with Huntington's disease may result from molecular mutations that block the transport of nutrients within cells.”
“RNA Interference Genetic Screen Suggests New Targets for Cancer Therapies”
(May 29) National Cancer Institute reports, “Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have developed a new method to identify genes that keep cancer cells active and that could be potential targets of anticancer therapies.”
“RNA Interference Gene Therapy Takes Two Steps Forward, One Step Back”
(May 28) Science Daily reports, “Three years ago Mark Kay, MD, PhD, published the first results showing that a hot new biological phenomenon called RNA interference was an effective gene-therapy technique in mice.”
“New pathways for autoimmune treatment identified”
(last accessed 2/2008)
(May 28) Medical News Today reports, “A rare genetic defect that can trigger a host of diseases from type 1 diabetes to alopecia has helped explain the imbalance of immune regulator and killer cells in autoimmune disease.”
“Nobel Laureate Nüsslein-Volhard To Discuss Mysteries Of Genetics”
(May 28) Medical News Today reports, “Why do children look like their parents? How does an embryonic cell know how to become an eye rather than an eyelash? How do simple egg cells develop into so many different life forms?”
“Researchers Identify Genetic Defects That Cause Main Types Of Non-Hodgkin Lymphoma, Paving The Way For Potential New Targeted Therapies”
(May 27) Medical News Today reports, “Researchers will report on the discovery of genetic defects that cause particular types of non-Hodgkin lymphoma (NHL), making these genes rational targets for new anti-lymphoma treatments, in the next issue of Blood.”